new biotech drug on the horizon for rheumatoid arthritis called Orencia (oh-REN-see-ah)

You'll hear about a new biotech drug on the horizon for rheumatoid arthritis called Orencia (oh-REN-see-ah).

Orencia (abatacept) is an immune modulator. It inhibits T-cell activation...but it works "upstream" from where TNF blockers work.

This means that Orencia reduces the production of tumor necrosis factor plus other immune modulators. Orencia will be an IV option for patients who don't respond to TNF blockers or other disease-modifying antirheumatic drugs (DMARDs).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote